These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Competitive antagonism at thromboxane receptors in human platelets. Armstrong RA, Jones RL, Peesapati V, Will SG, Wilson NH. Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580 [Abstract] [Full Text] [Related]
3. Antagonistic action of AA-2414 on thromboxane A2/prostaglandin endoperoxide receptor in platelets and blood vessels. Imura Y, Terashita Z, Shibouta Y, Inada Y, Nishikawa K. Jpn J Pharmacol; 1990 Jan; 52(1):35-43. PubMed ID: 2137886 [Abstract] [Full Text] [Related]
4. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors. Rajtar G, Cerletti C, Castagnoli MN, Bertelé V, de Gaetano G. Biochem Pharmacol; 1985 Feb 01; 34(3):307-10. PubMed ID: 3918536 [Abstract] [Full Text] [Related]
5. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Lumley P, White BP, Humphrey PP. Br J Pharmacol; 1989 Jul 01; 97(3):783-94. PubMed ID: 2527074 [Abstract] [Full Text] [Related]
6. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. Mais DE, Burch RM, Saussy DL, Kochel PJ, Halushka PV. J Pharmacol Exp Ther; 1985 Dec 01; 235(3):729-34. PubMed ID: 3001275 [Abstract] [Full Text] [Related]
7. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM, Wu TS, Teng CM. Br J Pharmacol; 1994 Mar 01; 111(3):906-12. PubMed ID: 8019768 [Abstract] [Full Text] [Related]
8. AH6809, a prostaglandin DP-receptor blocking drug on human platelets. Keery RJ, Lumley P. Br J Pharmacol; 1988 Jul 01; 94(3):745-54. PubMed ID: 2460179 [Abstract] [Full Text] [Related]
9. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets. Hamid S, Whittle BJ. Br J Pharmacol; 1985 May 01; 85(1):285-90. PubMed ID: 2992652 [Abstract] [Full Text] [Related]
10. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to guinea-pig platelets. Halushka PV, Mais DE, Garvin M. Eur J Pharmacol; 1986 Nov 12; 131(1):49-54. PubMed ID: 3816947 [Abstract] [Full Text] [Related]
11. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Giles H, Leff P, Bolofo ML, Kelly MG, Robertson AD. Br J Pharmacol; 1989 Feb 12; 96(2):291-300. PubMed ID: 2924081 [Abstract] [Full Text] [Related]
12. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate. Karasawa A, Kawakage M, Shirakura S, Higo K, Kubo K, Ohshima E, Obase H. Arzneimittelforschung; 1991 Dec 12; 41(12):1230-6. PubMed ID: 1840011 [Abstract] [Full Text] [Related]
13. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H, Stegmeier K. Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261 [Abstract] [Full Text] [Related]
14. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets. Mais DE, Kochel PJ, Saussy DL, Halushka PV. Mol Pharmacol; 1985 Aug 01; 28(2):163-9. PubMed ID: 2991736 [Abstract] [Full Text] [Related]
15. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist. Ogletree ML, Harris DN, Schumacher WA, Webb ML, Misra RN. J Pharmacol Exp Ther; 1993 Feb 01; 264(2):570-8. PubMed ID: 8437108 [Abstract] [Full Text] [Related]
16. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K, Halushka PV, Yan YT, Wong PY. J Pharmacol Exp Ther; 1994 Sep 01; 270(3):1192-6. PubMed ID: 7932171 [Abstract] [Full Text] [Related]
17. 9 alpha-homo-9,11-epoxy-5,13-prostadienoic acid analogues: specific stable agonist (SQ 26, 538) and antagonist (SQ 26, 536) of the human platelet thromboxane receptor. Harris DN, Phillips MB, Michel IM, Goldenberg HJ, Heikes JE, Sprague PW, Antonaccio MJ. Prostaglandins; 1981 Aug 01; 22(2):295-307. PubMed ID: 6270744 [Abstract] [Full Text] [Related]
18. The use of synthetic thromboxane A2 (TXA2-S) and a new class of thromboxane antagonists, indole-2-propanoic acids to characterize the thromboxane receptor. Gillard JW, Morton HE, Fortin R, Yoakim C, Girard Y, Lord A, Ethier D, Leveille C, Letts G, Evans J. Prog Clin Biol Res; 1989 Aug 01; 301():579-83. PubMed ID: 2529557 [No Abstract] [Full Text] [Related]
19. Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets. Miki I, Kishibayashi N, Nonaka H, Ohshima E, Takami H, Obase H, Ishii A. Jpn J Pharmacol; 1992 Jul 01; 59(3):357-64. PubMed ID: 1434130 [Abstract] [Full Text] [Related]
20. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. Le Breton GC, Venton DL, Enke SE, Halushka PV. Proc Natl Acad Sci U S A; 1979 Aug 01; 76(8):4097-101. PubMed ID: 291066 [Abstract] [Full Text] [Related] Page: [Next] [New Search]